Previous 10 |
Neximmune (NEXI): FY GAAP EPS of -$26.42.Cash and cash equivalents of $5MPress Release For further details see: Neximmune reports FY results
In 2020, advanced two product candidates into Phase 1/2 clinical trials while strengthening Board of Directors and management team Completed successful $126M initial public offering (IPO) in February 2021 to fund continuing operations through the second quarter of 2022 Additional ...
Cantor Fitzgerald analyst Alethia Young has initiated shares of NexImmune (NEXI) with an overweight rating and a $35 price target.That represents upside of ~70% from yesterday's closing price of $20.63.Young says her bullishness is based on the company's novel technology, Artificial Immune Mo...
Listen on the go! A daily podcast of Wall Street Breakfast will be available by 8:00 a.m. on Seeking Alpha, iTunes, Stitcher and Spotify. Economic reports in the week ahead Investors will continue to evaluate the impact of the congressional vote on stimulus in the week ahead and the direction...
Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha, Apple Po...
GAITHERSBURG, Md., March 02, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to orchestrate a targeted immune response by directing the function of antigen-specific T cells, today anno...
Rapha Capital Management Announces Successful Initial Public Offering of Portfolio Company NexImmune Inc. - NexImmune Raises Gross Proceeds of $126.5M in Upsized IPO - Legacy SPIVs Establish Rapha Capital's Expertise in Identifying Disruptive Technologies PR Newswire ...
Barer & Son Capital and Hibiscus Capital Management Announce Successful Initial Public Offering of Portfolio Company NexImmune Barer & Son Capital and Hibiscus Capital Management Announce Successful Initial Public Offering of Portfolio Company NexImmune NexImmune Rai...
GAITHERSBURG, Md., Feb. 17, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc. (Nasdaq: NEXI), a clinical-stage biotechnology company developing a novel approach to immunotherapy designed to employ the body’s own T cells to generate a specific, potent and durable immune response, today announc...
News, Short Squeeze, Breakout and More Instantly...
A look at the top 10 most actives in the United States SunPower Corporation (SPWR) rose 31.3% to $0.9396 on volume of 186,118,381 shares Selina Hospitality PLC (SLNA) fell 29.7% to $0.026 on volume of 168,426,091 shares NVIDIA Corporation (NVDA) fell 0.8% to $122.59 on volume of 168,211,0...
A look at the top 10 most actives in the United States Agape ATP Corporation (ATPC) rose 112.1% to $0.3033 on volume of 62,336,784 shares Warrantee Inc. (WRNT) rose 27.8% to $0.372 on volume of 55,635,565 shares Adial Pharmaceuticals Inc (ADIL) rose 110.3% to $2.2295 on volume of 54,549,4...
A look at the top 10 most actives in the United States Serve Robotics Inc. (SERV) rose 187.1% to $7.55 on volume of 255,453,115 shares 60 Degrees Pharmaceuticals Inc. (SXTP) rose 10.2% to $0.271 on volume of 224,640,171 shares NVIDIA Corporation (NVDA) fell 2.6% to $117.93 on volume of 21...